Patient info Open main menu

Xonvea® 10 mg/10 mg gastro-resistant tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
10 mg / 10 mg
Contains active substances:

Patient leaflet - Xonvea 10 mg / 10 mg gastro-resistant tablets

1. What Xonvea is and what it is used for

What Xonvea is

Xonvea contains two medicines (‘active substances’) called: ‘doxylamine succinate’ and ‘pyridoxine hydrochloride’.

  • Doxylamine succinate belongs to a group of medicines called ‘antihistamines’.
  • Pyridoxine hydrochloride is another name for Vitamin B6.

What Xonvea is used for

Xonvea is used in pregnant women aged 18 years and older, to help stop them feeling sick (nausea) and being sick (vomiting). It is used when changes in diet or other non-medicine treatments have not worked.

2. What you need to know before you take Xonvea

Do not take Xonvea if:

  • you are allergic to doxylamine succinate or other antihistamines (such as diphenhydramine), pyridoxine hydrochloride or any of the other ingredients of this medicine (listed in section 6)
  • you are taking medicines for depression called ‘monoamine oxidase inhibitors’ (MAOIs)

Do not take Xonvea if any of the above apply to you. If you are not sure, talk to your doctor, pharmacist or nurse before taking Xonvea.

Warnings and precautions

Talk to your doctor or pharmacist or nurse before taking Xonvea if you have ever had:

  • asthma
  • increased eye pressure
  • an eye problem called ‘narrow angle glaucoma’
  • a stomach ulcer
  • a blockage in your gut, between your stomach and small intestine
  • a blockage in your bladder.

Also, talk to your doctor or pharmacist or nurse before taking Xonvea if:

  • you are taking cough or cold medicines, sleeping medicines or certain pain medicines
  • you have been drinking alcohol.

If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before taking Xonvea.

If you suffer from severe nausea and vomiting of pregnancy, a condition called hyperemesis gravidarum, you have to be treated by a specialist.

If you are having a urine drug screen, taking Xonvea may show ‘false positive’ results for methadone, opiates, and phencyclidine phosphate (PCP) when some test methods are used. If this happens, a more specific test can be performed.

Children and adolescents

Xonvea is not meant for use in children under 18 years old. It is not known if Xonvea is safe and effective in this age group.

Vitamin B

Talk to your doctor, pharmacist or nurse before taking any additional vitamin B – this could be through your diet, from supplements or multi-vitamins.

Other medicines and Xonvea

Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription, and herbal medicines.

In particular, do not take Xonvea and tell your doctor or pharmacist or nurse if you are taking any of the following:

  • Medicines for depression called ‘monoamine oxidase inhibitors’ (MAOIs) - using these medicines with Xonvea can make side effects worse and last longer.
  • Medicines such as cough and cold medicines, sleeping medicines or certain pain medicines (called central nervous system depressants) - using any of these with Xonvea can make you feel very sleepy. This can make you fall over or cause other accidents.

Xonvea with alcohol

Do not drink alcohol while taking Xonvea.

Pregnancy and breast-feeding

Xonvea is for use in pregnant women.

If you are breastfeeding, a decision should be made with your doctor whether to discontinue breast-feeding or to discontinue the drug. This is because Xonvea can pass into your breast milk and may harm your baby.

Driving and using machines

Do not drive, cycle or use any tools or machines while taking this medicine. This is because you may feel sleepy after taking Xonvea. If this happens do not do other activities that need your full attention - unless your doctor tells you it is ok to do so.

Xonvea contains Allura red AC aluminium lake (E 129), benzoic acid (E 210) and sodium.

This medicine contains the azo colouring agent Allura red AC aluminium lake (E 129) which may cause allergic reactions.

This medicine contains 0.02 micrograms benzoic acid (E 210) in each gastro-resistant tablet.

This medicine contains less than 1 mmol sodium (23 mg) per gastro-resistant tablet, that is to say essentially ‘sodium-free’.

3. How to take Xonvea

Always take this medicine exactly as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure.

How much to take

Your doctor will start you on a low dose and possibly increase it - this will depend on how well the medicine works for you.

How to start taking Xonvea and increase your dose, if needed:

  • Day 1

    • Take 2 tablets, by mouth at bedtime.
  • Day 2

    • Take 2 tablets, by mouth at bedtime.
    • If your nausea and vomiting is better or controlled on Day 2, continue to take 2 tablets every night at bedtime. This will be your usual dose unless your doctor, pharmacist or nurse tells you otherwise.
  • Day 3

    • If you still had nausea and vomiting on Day 2, take 1 tablet in the morning and 2 tablets at bedtime, by mouth on Day 3
  • Day 4

    • If your nausea and vomiting was better or controlled on Day 3 continue to take 1 tablet in the morning and 2 tablets at bedtime by mouth each day. This will be your usual dose unless your doctor, pharmacist or nurse tells you otherwise.
    • If you still had nausea and vomiting on Day 3, take 1 tablet in the morning, 1 tablet in the mid-afternoon, and 2 tablets at bedtime, by mouth on Day 4. This will be your usual dose unless your doctor, pharmacist or nurse tells you otherwise.

Do not take more than 4 tablets each day (1 in the morning, 1 in the mid-afternoon, and 2 at bedtime).

Taking this medicine

  • Take Xonvea on an empty stomach.
  • Swallow the tablet whole with a glass of water.
  • Do not crush, chew, or split the tablets before swallowing to preserve the effect of this medicine.

If you cannot swallow Xonvea tablets whole, tell your doctor, pharmacist or nurse.

If you take more Xonvea than you should

If you take more Xonvea than you should, stop taking Xonvea and talk to a doctor or go to a hospital straight away, even if you feel well. Take the medicine pack with you. The following effects may happen: feeling restless, sleepy or dizzy, dry mouth, larger black part of the eye (dilated pupils), confusion, fast heart rate.

If the amount of medicine in your body is very high, you may also have fits, muscle pain or weakness or sudden severe kidney problems. These may even be life-threatening. If you have these signs - stop taking Xonvea and talk to a doctor or go to a hospital straight away.

If you stop taking Xonvea

Do not stop taking Xonvea without talking to your doctor first. If you stop taking this medicine suddenly your feeling sick (nausea) and being sick (vomiting) may come back. Your doctor will tell you how to stop taking this medicine slowly over time to help avoid this.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Very common: may affect more than 1 in 10 people

  • feeling very sleepy.

Common: may affect up to 1 in 10 people

  • feeling dizzy
  • feeling tired
  • dry mouth.

Not known: frequency cannot be estimated from the available data

  • hypersensitivity (allergic reaction)
  • feeling anxious, difficulty in sleeping (insomnia), nightmares, feeling disorientated
  • headaches or migraines
  • tingling, pricking or numbness of skin
  • restlessness and a need to move constantly
  • problems with eyesight or blurred vision
  • sensation of spinning dizziness
  • difficulty breathing, awareness of heartbeat or increased heart rate
  • full or bloated feeling, stomach pains, constipation or diarrhoea
  • excessive sweating, skin reactions such as itchiness or rash
  • difficulties or pain with passing urine
  • discomfort in the chest
  • general discomfort or feeling irritable

Other side effects reported with medicines in the same drug class as doxylamine

Anticholinergic effects include (blockage of the activity of organs that receive nerve impulses through a substance called acetylcholine): dry mouth, nose and throat; double vision (diplopia); ringing or humming in the ears (tinnitus); inflammation of the inner ear which develops within a short time (acute labyrinthitis); shaking (tremors) and nervousness; involuntary repetitive movements of the face (facial dyskinesia). In addition, feeling of tightness in the chest, thick mucus in the chest (bronchial secretions); high-pitched whistling sound often associated with difficulty in breathing (wheezing); stuffy nose; feeling chills; early menses; altered state of mind such as hallucinations, delusions, confusion and disturbed thoughts (toxic psychosis); or feeling faint have been reported.

Rarely, low levels of white blood cells (agranulocytosis), reduced blood in the body due to increased destruction of blood cells (haemolytic anaemia), decreased clotting blood cells (thrombocytopenia), decreased red, white and clotting cells in the blood (pancytopenia), and increased appetite, sometimes with weight gain, have been reported.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Xonvea

  • Keep out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the blister and on the carton after EXP. The expiry date refers to the last day of that month.
  • This medicine does not require any special storage conditions.
  • If your medicine becomes discoloured or shows any sign of deterioration, return it to your pharmacist.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. Contents of the pack and other information

What Xonvea contains

  • The active substances are doxylamine succinate (an antihistamine) and pyridoxine hydrochloride (vitamin B6). Each gastro-resistant tablet contains 10 mg of doxylamine succinate and 10 mg of pyridoxine hydrochloride.
  • The other ingredients are, carnauba wax, croscarmellose sodium, hypromellose (E 464), indigo carmine aluminium lake (E 132), macrogol 400 (E 1521), macrogol 8000 (E 1521), magnesium stearate, magnesium trisilicate, methacrylic acid-ethyl acrylate copolymer (1:1), microcrystalline cellulose (type 102), Allura red AC aluminium lake (E 129), polysorbate 80 (E 433), propylene glycol (E 1520), colloidal anhydrous silica, shellac, simethicone emulsion (30%) (contains benzoic acid (E 210)), sodium hydrogen carbonate (E 500), sodium lauryl sulfate (E 487), talc (E 553b), titanium dioxide (E 171), triethyl citrate and simethicone.

What Xonvea looks like and contents of the pack

  • Xonvea gastro-resistant tablets are white, round, and film-coated with a pink image of a pregnant woman on one side.
  • Xonvea is available in blister packs containing 20 or 30 tablets.

Manufactured by

Laboratorios Liconsa S.A., Avda. De Miralcampo 7, Pol. Ind. Miralcampo, 19200, Azuqueca De Henares (Guadalajara), Spain.

Procured from within the EU. Repackaged by the Product Licence Holder: MPT Pharma Ltd., Westgate Business Park, Unit 5-7 Tintagel Way, Aldridge, Walsall, WS9 8ER.

PL 33532/1633

Leaflet dated 28th May 2026

Leaflet coded XXXXXXXXX

Xonvea® is a registered trademark of Duchesnay Inc.

To request a copy of this leaflet in Braille, large print or audio please call 01922 745645 and ask for the Regulatory Department.

POM

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 33532/1633

Last revision stated in the text: 28 May 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Xonvea 10 mg / 10 mg gastro-resistant tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substances Pyridoxine, Doxylamine
Strength 10 mg / 10 mg
Pharmaceutical form Gastro-resistant tablet
White, round, film-coated tablet with a pink image of a pregnant woman on one side.
How is it taken Oral
Excipients Microcrystalline cellulose, Magnesium trisilicate, Croscarmellose sodium, Magnesium stearate, Colloidal anhydrous silica, Hypromellose (E 464), Macrogol (E 1521), Methacrylic acid-ethyl acrylate copolymer (1:1) Talc (E 553b), Sodium hydrogen carbonate (E 500), Sodium laurilsulfate (E 487), Triethyl citrate, Simethicone emulsion (contains benzoic acid (E 210)), Titanium dioxide (E 171), Polysorbate 80 (E 433), Waxing, Carnauba wax, Shellac, Allura red AC aluminum lake (E 129), Propylene glycol (E 1520), Indigo carmine aluminum lake (E 132), Simethicone
Pack sizes 20 tablet, 30 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 42 months
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Aminoalkyl ethers
  1. R Respiratory system drugs
    1. R06 Antihistamines for systemic use
      1. R06A Antihistamines for systemic use
        1. R06AA Aminoalkyl ethers, systemic antihistamines
          1. R06AA59 doxylamine, combinations
Marketing authorisation PL 44081/0006 (first authorised 27 June 2024), PLPI 33532/1633
Marketing authorisation holder Exeltis Healthcare S.L.
Codes GTIN 8437018658893, 8437024360834 · BNF 04060000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.